DNTH
Price
$21.46
Change
+$0.07 (+0.33%)
Updated
Jul 30, 01:05 PM (EDT)
Capitalization
689.51M
NKTR
Price
$22.91
Change
-$0.00 (-0.00%)
Updated
Jul 30, 01:24 PM (EDT)
Capitalization
396.35M
8 days until earnings call
Interact to see
Advertisement

DNTH vs NKTR

Header iconDNTH vs NKTR Comparison
Open Charts DNTH vs NKTRBanner chart's image
Dianthus Therapeutics
Price$21.46
Change+$0.07 (+0.33%)
Volume$100
Capitalization689.51M
Nektar Therapeutics
Price$22.91
Change-$0.00 (-0.00%)
Volume$300
Capitalization396.35M
DNTH vs NKTR Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. NKTR commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and NKTR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 30, 2025
Stock price -- (DNTH: $21.44 vs. NKTR: $22.91)
Brand notoriety: DNTH: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 101% vs. NKTR: 37%
Market capitalization -- DNTH: $689.51M vs. NKTR: $396.35M
DNTH [@Biotechnology] is valued at $689.51M. NKTR’s [@Biotechnology] market capitalization is $396.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $315.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while NKTR’s TA Score has 6 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 5 bearish.
  • NKTR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а +3.38% price change this week, while NKTR (@Biotechnology) price change was -6.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.96%. For the same industry, the average monthly price growth was +16.15%, and the average quarterly price growth was +45.09%.

Reported Earning Dates

DNTH is expected to report earnings on May 12, 2025.

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-1.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($690M) has a higher market cap than NKTR($396M). NKTR YTD gains are higher at: 64.229 vs. DNTH (-1.651). NKTR has higher annual earnings (EBITDA): -97.97M vs. DNTH (-116.76M). DNTH has more cash in the bank: 263M vs. NKTR (219M). DNTH has less debt than NKTR: DNTH (1.4M) vs NKTR (100M). NKTR has higher revenues than DNTH: NKTR (87.2M) vs DNTH (6.52M).
DNTHNKTRDNTH / NKTR
Capitalization690M396M174%
EBITDA-116.76M-97.97M119%
Gain YTD-1.65164.229-3%
P/E Ratio3.24N/A-
Revenue6.52M87.2M7%
Total Cash263M219M120%
Total Debt1.4M100M1%
FUNDAMENTALS RATINGS
DNTH vs NKTR: Fundamental Ratings
DNTH
NKTR
OUTLOOK RATING
1..100
1153
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
49100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4737
P/E GROWTH RATING
1..100
6783
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DNTH's Valuation (52) in the null industry is in the same range as NKTR (82) in the Biotechnology industry. This means that DNTH’s stock grew similarly to NKTR’s over the last 12 months.

DNTH's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for NKTR (100) in the Biotechnology industry. This means that DNTH’s stock grew somewhat faster than NKTR’s over the last 12 months.

DNTH's SMR Rating (95) in the null industry is in the same range as NKTR (99) in the Biotechnology industry. This means that DNTH’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's Price Growth Rating (37) in the Biotechnology industry is in the same range as DNTH (47) in the null industry. This means that NKTR’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (67) in the null industry is in the same range as NKTR (83) in the Biotechnology industry. This means that DNTH’s stock grew similarly to NKTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHNKTR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIEMX13.03N/A
N/A
SEI Emerging Markets Equity F (SIT)
BKPIX62.46N/A
N/A
ProFunds Banks UltraSector Inv
JBATX30.48N/A
N/A
JHancock Balanced R2
HIGUX21.56N/A
N/A
Carillon Eagle Growth & Income R6
MSIBX19.78N/A
N/A
Morgan Stanley Inst Passport ovrs eq A

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-3.77%
IMNM - DNTH
53%
Loosely correlated
-2.08%
XNCR - DNTH
51%
Loosely correlated
-2.66%
CRNX - DNTH
48%
Loosely correlated
-3.50%
SYRE - DNTH
48%
Loosely correlated
-1.30%
ERAS - DNTH
48%
Loosely correlated
-8.82%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with SLS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-3.13%
SLS - NKTR
42%
Loosely correlated
-5.83%
ARCT - NKTR
39%
Loosely correlated
-9.18%
AMLX - NKTR
38%
Loosely correlated
-0.38%
ABCL - NKTR
36%
Loosely correlated
-4.67%
RXRX - NKTR
36%
Loosely correlated
-5.71%
More